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INTRODUCTION & BACKGROUND – Research findings are increasingly recognized as an 
important input in the formation of health policy. There is concern that research findings are not 
being utilized by health policy-makers to the extent that they could be. Several models of policy 
processes and research utilization have been proposed in the literature, indicating the many ways 
research can influence policy-making. The factors influencing this utilization are emerging in the 
literature, including but not limited to: the interaction between researchers and policy-makers, and 
the relevance and timeliness of research findings. Most of this research has come from Western 
societies and there is still little known about this issue in developing countries. The object of this 
study was to determine these factors by exploring the policy-making involved in implementing 
Mali’s essential medicines list, a health policy common in developing countries 
METHODS – Many methods have been used in this field of research, largely dominated by the 
qualitative tradition. A case study of the selection and updating of Mali’s essential medicines list 
was undertaken using a phenomenological approach to the analysis. In-depth, semi-structured 
interviews and a natural group discussion were held with national policy-makers, most specifically 
members of the national commission that selects and updates the country’s list. A document 
analysis was also performed. 
RESULTS – Factors emerging from the textual data that appear to be influencing the utilization of 
health research findings for these policy-makers include: access to information, relevance of the 
research, utilization of research perceived as a time consuming process, trust in the research, 
authority of those who presented their view, competency in research methods, priority or relative 
importance of research in the policy process, and accountability. 
CONCLUSION – Improving the transfer of research to policy will require efforts from researchers, 
policy-makers, and third parties. Through collaboration between researchers and policy-makers, 
increased production and dissemination of relevant and useful research, and continued and 
improved technical support from networks and multi-national organizations, policy-makers from 
developing countries will be better equipped to make informed decisions concerning their health 
policy issues. 
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CHAPTER I – INTRODUCTION 
 
“If we, as health workers, or teachers, or students, or civil servants do not feel 
that we, and the groups or organizations we belong to, have some power to alter 
policy that affects our lives, or the lives of those around us, why get up in the 
morning?” 
- Gill Walt (1) 
 
Research utilization in health policy-making 
Many health researchers and those who fund health research would agree with 
Walt’s statement regarding their desire to influence policy. The health research 
community would like to believe that the work they produce and support is 
influencing practice and policy and consequently leading to actual improvements 
in health care delivery. Despite the neutral and objective standpoint usually taken 
in their work, the research community considers the results they produce to be 
important. Probably the single most common recommendation in all published 
articles in all academic journals is for more research. Health research funding 
agencies distribute massive amounts of financial resources every year to support 
researchers and research institutions. Clearly, the health research community 
perceives a great need for this information. 
 
The concept of evidence-based medicine was first introduced in 1991 as an 
approach to teaching medical practice, promoting the utilization of empirical 
research findings by clinical practitioners (2). This concept has been extended to 
policy as well. The extent to which research actually influences the health policy 
process is however unclear (3). Various models of policy processes have 
emerged in this field demonstrating that there are many ways in which research 
can influence policy (1, 4). Research findings are only one of the many types of 
information required for good policy-making. Other concerns such as local 
resources, values and needs also come into the policy process. 
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Research findings are however increasingly being recognized as critical inputs in 
health planning and policy-formation and most would agree that their role is 
crucial to developing sound health policies. Still, it is widely recognized that the 
level of research utilization by policy-makers is lower than it could be (3). 
Recognition of the importance of bridging the “know-do” gap is increasing around 
the world and has resulted in an emergence of various institutions involved in 
analyzing this problem and promoting the transfer of knowledge to practice and 
policy (5). 
 
Studying research to policy 
The study of research’s influence on policy has had a long and rich background 
and continues to grow. Early work in this field focused on the utilization of social 
science knowledge in government and public policy and discussed the general 
lack of utilization of this information source (6, 7). The field expanded and 
advanced to study the usefulness and utilization of various types of research 
findings in policy-making, with many studies focused on health research including 
health technology assessments and economical evaluations (see for example: 
(8, 9)). Within the field of evidence-based medicine, there have been discussions 
on what constitutes the best type of evidence (10), discussing key differences 
between basic and applied research. More recently, there have been hierarchies 
of evidence discussed, with systematic reviews ranked at the top (11), and 
described as “the heart of evidence-based practice” in various medical fields 
such as nursing (12). These concepts have also been applied to policy-making. 
Some studies have focused on the factors influencing the utilization of systematic 
reviews by public health decision-makers (13, 14), and more recently how to 
improve the usefulness of these reviews for health managers and policy-makers 
(15). 
 
While the body of literature examining the factors influencing the utilization of 
research findings by policy-makers is increasing in depth and scope, most of the 
findings from this field are based on studies from industrialized countries, and 
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there is still relatively little known about these factors in developing countries 
(16). There is therefore a great need for more studies in this field in these 
economically strained settings. Policy-makers from these countries need the best 
information from all sources in order to make well-informed decisions. With their 
limited resources these countries have much to gain from well-informed health 
policies (17). 
 
The research presented here identified factors influencing the utilization of 
research findings by health policy-makers in a developing country. This study did 
this by exploring Malian policy-makers’ perceptions of the utilization of research 
findings for decisions made during the implementation of a health policy common 
in developing countries: the selection and updating of the national essential 
medicines list (EML).  
 
Objectives 




To improve the transfer of information from research to policy, increasing 
informed decision-making by health policy-makers in developing countries, by 
identifying the factors influencing the utilization of such information. 
 
Specific objectives 
1. Identify key decision-makers and key information providers involved in the 
selection and updating processes for Mali’s EML. 
2. Explore and map out the information transfer process and networking 
involved in the selection and update of Mali’s EML. 
3. Explore the decision-making process involved in the selection and 
updating Mali’s EML. 
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4. Identify policy-makers’ perceptions of the utilization of research findings in 
the decision-making process, the importance of research findings in the 
process in general, and specific aspects of different research findings that 
make them useful. 
5. Identify to what extent research findings were actually utilized in the 
selection process, examples of research used, and the kind of utilization 
(enlightenment, confirming beliefs, weapons for support, etc.). 
6. Report the findings at national and international levels in both French and 
English languages. Also, publish the findings in a relevant peer-reviewed 
journal for further dissemination. 
 
Thesis layout 
The research on which this thesis is based was written up in a research article 
that was submitted for publication in an international peer-reviewed scientific 
journal on May 22, 2006. The article is found in Chapter IV. The research article 
is the primary component of this thesis, however an elaboration on several 
important concepts and ideas are presented here in order to reflect on issues 
that could not be included in the article. The author has attempted to minimize 
repetition. 
 
Having laid out the rationale and objectives for the present study in this 
introductory chapter, the thesis will next provide the background into some of the 
specific issues and concepts that are important to this study in Chapter II. It will 
give an overview of the particular policy that was analyzed in this study – an EML 
– and some of the contextual factors of the setting in which it was studied – Mali. 
The chapter will then highlight some of the important models and theories of 
policy processes and research utilization in policy-making that can be found in 
the literature. The chapter will also provide an overview of past research findings 
on this particular topic.  
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The third chapter will review the methodologies that are important to this general 
field of research and those that have been used in the past, highlighting the 
strengths and weaknesses of the various methods for this particular research 
topic. An overview of issues related to the use of a qualitative design will also be 
included, since this field of research is largely dominated by the qualitative 
discipline. The chapter will then briefly discuss the design and methodology used 
in the present study, and the use of the phenomenological approach for 
analyzing the data. 
 
The research article is then provided in Chapter IV. Lastly, Chapter V will 
elaborate and discuss issues that could not be covered in the article, due to the 
limits required from a scientific journal. This will include a description of the 
diversions from the protocol, a brief look at the factors that emerged from this 
study that are unique in the literature, some additional implications of the 
findings, and finally some concluding remarks. 
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CHAPTER II – BACKGROUND 
 
Essential medicines lists 
In 1975 the World Health Organization (WHO) introduced the global concept of 
essential medicines with the first model essential drug list introduced in 1977.  
The name was later changed to an essential medicines list (EML) to reflect the 
fact that the term medicine is commonly used in clinical practice to describe 
pharmaceutical preparations, whereas the term drug can often be confused with 
illicit or recreational drugs. Updates every two years have lead to the current 14th 
model list (18). According to the WHO, essential medicines are “those that satisfy 
the priority health care needs of the population”, and are intended to be 
“available within the context of functioning health systems at all times in 
adequate amounts, in the appropriate dosage forms, with assured quality, and at 
a price the individual and the community can afford” (19).  
 
Introducing an EML along with a national medicines policy is widely accepted as 
an effective way of improving the access to, and supply of medicines, lowering 
their costs, and improving rational use. There is relatively little information on the 
effectiveness of this policy in improving rational use in developing countries (20). 
That stated, this research was not an attempt to legitimize, argue against, or 
even question the use of an EML. Instead, this research took for granted that an 
EML was present in the case studied and focused on the selection and updating 
of the specific medicines on the list and the process that was experienced by the 
national health policy-makers in making these decisions. 
 
The WHO model list is the reference document usually used as a starting point 
for a country’s national list, however the selection decisions for each list require 
additional information from monitoring and research in order to appreciate the 
country’s specific health situation (21). Key textbooks, such as Managing Drug 
Supply – often considered the expert text or “yellow bible” in this field – describe 
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the various criteria used for choosing medicines for the list (21, 22). These 
include: relevance to the pattern of prevalent diseases, proven efficacy & safety, 
adequate scientific data and evidence of performance in a variety of settings, 
adequate quality, favourable cost-benefit ratio, desirable pharmacokinetic 
properties, possibilities for local manufacture, and availability as single 
compounds. The extent to which a national selection committee makes informed 
decisions on which medicines to be included will no doubt play an important role 
in the success of this medicines policy. 
 
Study setting 
This study was conducted in the landlocked West African country of Mali. The 
French colonized the region in the late 19th century and brought with them the 
country’s current official language. Most individuals’ native tongue is however of 
local dialect, such as Bambara in the capital region of Bamako. With a GDP of 
4.9 billion dollars and a population of 13.1 million, Mali is one of the poorest 
countries in the world. The economy is primarily based on agriculture, and there 
is a literacy rate of 19%. A few key health indicators include a life expectancy of 
48.3 years, a child mortality rate of 21.9%, and an HIV prevalence of 1.9% (23). 
The total expenditure on health is 4.5% of GDP, with private expenditure 
accounting for 49.2% of total expenditure (24). 
 
Like many developing countries, Mali has an EML. The Malian list is composed 
of 271 molecules and 426 medicines of different forms and dosages for a global 
list (25). Four separate lists are provided for community based health centers 
(with and without a medical doctor), district health centers and hospitals. Several 
of the medicines on Mali’s EML are not present on the WHO model list. The 
country’s EML also includes an extra section for “improved traditional medicines.” 
It is one of very few countries with traditional medicines incorporated into its 
national list and is the location of a WHO collaborating centre for Traditional 
Medicines. The various additional medicines on the EML provided an excellent 
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opportunity for discussing specific decisions that might have been influenced by 
research findings. 
 
The country’s EML is updated approximately every two years by a national 
commission organized by the Direction of Pharmaceuticals and Medicines of the 
Ministry of Health. The commission is composed of various civil servants within 
the Ministry, including pharmacists, managers and directors of various health 
programs and institutes such as those fighting malaria, tuberculosis and 
HIV/AIDS. The commission also includes local medical practitioners and health 
workers considered experts in their field. Technical advisors of the WHO and the 
European Union also participate in this process. The country’s official criteria for 
the selection of medicines is similar to those described above and, at the time of 
the study, specifically highlighted: harmlessness, efficacy, relevance to the 
disease pattern, availability on the international market, and cost-effectiveness 
(26). Since research findings potentially have much to contribute to these criteria, 
the factors influencing their utilization throughout the process of selecting the 
medicines for the EML, as perceived by policy-makers, were examined.  
 
Theoretical issues 
Policy-making is diverse and complex and there are many ways in which 
research findings may be utilized in this process. Various actors are involved and 
a vast number of information sources can be utilized, all potentially influencing 
the policy at different stages in its development. A number of models and 
theories have emerged in the literature attempting to explain and clarify the policy 
process and the influences that act within it, including the influence of health 
research findings. A comprehensive analysis of all these models and theories 
would be impossible (and unwarranted) in the limitations of a Masters thesis, 
especially one with a large field-study component. In addition, this research did 
not attempt to test any of these models or theories. However, an examination of 
these theoretical concepts is useful for obtaining a complete understanding of the 
present research and the issues that are essential to it. 
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The policy-making process 
In the literature examining the utilization of research findings in the policy 
process, the terms “decision-makers” and “policy-makers” are often used 
interchangeably. Decision-making can be referred to as a specific choice among 
several options whereas policy-making often refers to a group of decisions and 
how these decisions are put into practice (27). The term decision-making has 
also been used to describe decisions made by patients and practitioners in their 
utilization or delivery of various treatments, including issues related to evidence-
based medicine at the practice level – which could be referred to as practice 
policies. In this study, the term “policy-maker” has been adopted as a way of 
distinguishing individuals who make decisions – be it a single decision or several 
– that affect a policy, more specifically a service-related policy, from other health 
workers that make health decisions outside this policy arena. 
 
The policy process has long been described as composing of several phases or 
stages: agenda setting, policy formulation, implementation, and evaluation. 
Agenda setting involves policy-makers’ identification and focus on a particular 
problem. Policy-formulation is the phase where policies are initiated and 
potentially adopted. The implementation phase involves the execution of the 
policy through various government institutions. The final phase is evaluation and 
is increasingly recognized as an important part of the policy process. It can in 
itself be considered a type of research that aims to determine the success of the 
policy. The evaluation then potentially influences previous stages in the policy 
process. Many models in the literature use similar classifications, often breaking 
down the policy process into even more phases (28). 
 
Such “phases” models have been commonly used as frameworks when 
discussing the many areas where the various inputs (including health research 
findings) may be exerting their influence on policy-making. These phases have 
been described as acting in a linear sequence of events in the more top-down 
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rational models of policy processes. It is widely recognized that policy-making 
does not follow such a direct and linear process, and it has been argued that 
rational models can be misleading, resulting in an undue focus on higher levels 
of policy-decisions (29). For example, when considered from such a top-down 
point of view, the implementation phase would be considered as an 
administrative phase involving the simple carrying out of decisions made from 
above. According to a bottom-up approach – one that looks at the policy-process 
in a less linear and more interactive manner where actors in all phases of the 
policy process influence the development of the policy – the implementers play 
an important role in influencing the policy-making (1). Interactive models have 
been proposed in more bottom-up processes, where feedback mechanisms allow 
different phases to influence each other (30). 
 
There is widespread belief that these phases are in fact not distinct from one 
another. In an in-depth look at process and power in health policy, Walt highlights 
the complexity of the policy process stating that implementation of the policy 
cannot be separated from its formulation (1). Still, the structure of her book is 
essentially divided into these distinct phases. Indeed, it can prove helpful to 
break up the policy process in such a way in order to discuss the impact of 
various sources of information on the process. In looking at the present case of 
an EML policy, the agenda setting phase might be considered the stage where it 
was decided that supply, rational use, and costs of medicines should be 
improved. Looking at how research findings influenced such a decision would 
constitute an examination of research’s influence on the agenda setting phase. If 
one were to explore the decision made to use an EML, perhaps as a way of 
solving the problem of rational use, it could be considered as studying the 
formulation stage of the policy process. A study looking at the evaluation phase 
might constitute research measuring the impact of the essential medicines policy 
on rational use. Looking at whether or not such a study was used, would bring us 
back to one of the previous phases. Since the present study explored the 
utilization of research findings by policy-makers throughout their decisions 
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surrounding some of the details of the EML policy – the selection of the 
medicines for the list – it could be stated that this particular study focused on 
research findings’ influence on the implementation stage of the policy process. 
 
Other models described in this field include, the incrementalist models, pioneered 
by Lindblom, which describe policy-making as a series of many steps that lead to 
major changes and highlight the importance of the multitude of information 
sources and actors influencing policy-makers, including local needs and values 
(31). Network approaches similarly highlight the various actors influencing policy, 
focusing on the networks that exist within the particular policy-making community 
(3). Kingdon’s multiple streams approach on the other hand describes policy-
making in terms of the flow of politics, problems, and solutions (32). Issues of 
timing and relevance are key in this model since instances where these streams 
converge offer opportunities for influencing the policy. 
 
Many other models have been proposed in the literature, and this is by no means 
an exhaustive list. The models help to shed light on the complexity of policy-
making and highlight the fact that no specific model will be able to fully describe 
the development of every policy. As one health policy analyst states, the process 
is “best understood as a chaos of purposes and accidents” (29). The policy 
process can be thought to involve many phases, that are likely not distinctly 
separate from each other and do not flow in a linear fashion. In this process there 
are many influences coming from various actors, experiences and networks that 
may exert different levels of influence depending on the contextual setting and 
the links that have been established by the policy-makers. Additionally, the 
information provided by these influences may not always be available to policy-
makers, and may only enter into the policy process under particular 
circumstances. 
 
These models of policy processes offer several approaches to looking at where, 
and in what ways, various information sources may fit into the policy-making 
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process. In order to better comprehend how research findings can exert their 
influence on these complex policy processes, it is useful to analyze the various 
models and theories of research utilization that have emerged in the literature. 
 
Research utilization 
The term “research utilization” is in itself a complex concept with many different 
meanings. Perhaps the first to fully conceptualize the term was Weiss who 
categorized the concept into six types or models of research utilization: 
knowledge-driven, problem-solving, interactive, political, tactical, and 
enlightenment (4). The knowledge-driven and problem-solving models involve 
direct influence from research, starting with the research or the problem, 
respectively. The interactive and political models involve the selective retrieval of 
information from various sources, either to inform policy-makers’ decisions or as 
support for decisions already made. In the tactical model, the content is in fact 
irrelevant, as research is used as a tactic when policy-makers are required to 
perform some action. The enlightening model is one in which research gets used 
by “permeating” into policy. According to Weiss and others, the enlightening 
model is potentially the most important way in which social science research 
influences policy (4, 6, 7). This type of utilization has however been described as 
potentially the most difficult to measure (16). 
 
Weiss’ theories have been elaborated by others (33, 34). These models 
essentially describe research utilization as either directly influencing the policy 
(instrumental use), changing the policy-makers’ understanding of the issue 
(conceptual use), or as a form of support (symbolic). Nutley and colleagues’ 
conceptual type of research utilization highlights the fact that the final decision 
need not follow directly from researchers’ recommendations (34). This is the 
basis for the definition of research utilization the author chose to use for the 
present research. Specifically the word “considered” was an important criterion 
for determining what would constitute “utilized”, in the present study. This 
definition highlights the fact that there are many important inputs to policy-
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making, and does not undermine other actors’ influence in the policy process, 
including civic engagement and political will. The definition one chooses will 
affect the interpretation of the factors influencing research utilization. In adopting 
this definition, it is important to recognize that the final outcome of a policy-
decision may not be indicative of whether or not research has in fact been 
“utilized”. As is described in the article, policy-makers may “utilize” research 
findings and yet in the end decide not to implement them, at least according to 
the definition the author has chosen. The stages model of research utilization 
provided by Knott and Wildavsky is useful for understanding the fact that using 
research is not a single event (35). This model looks at research findings as a 
process in and of itself. The process involves: transmission, cognition, reference, 
effort, influence, and application. The basic concept is that research findings 
must first reach policy-makers, be read and understood by them, and then 
considered amongst other options before efforts can be made to adopt and 
implement them. 
 
Another way to view research utilization by policy-makers is through user-pull, 
producer-push, and interactive models (36, 37). The user-pull models focus on 
policy-makers actions to search, access and utilize research findings (pulling) as 
required by their needs and context. The producer-push models focus on 
researchers’ promotion and dissemination (pushing) of their research towards 
policy-makers, while the interactive models deal with the combined efforts of both 
groups to involve the other (interacting) through means such as having policy-
makers help in setting research agendas or the commissioning of studies by the 
policy-makers. It has been suggested that more research is needed that focuses 
on the user side of the interaction, since most studies measuring knowledge-
transfer strategies, especially those focused on clinical decisions, have focused 
on producer push models (38). As described above, the present research did just 
that, by focusing on policy-makers perceptions of the situation. 
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Caplan and colleagues have provided some of the most important work 
regarding the problems research has had in influencing policy through their ‘two-
communities’ theory of research utilization (7). Caplan’s empirical research, 
comparing the ‘two-communities’ theory with the knowledge-specific and policy-
maker constraint theories, indicated that such a theory could account for most of 
the reasons for the non-use of research findings (39). The essential concept 
behind the theory is that researchers and policy-makers have two competing 
worldviews, with different values and different interests. It has been the focus of 
many intervention strategies through the promotion of the idea that increasing the 
collaboration and personal contact between researchers and policy-makers will 
improve the uptake of research findings into the policy process. 
 
Finally, the interfaces and receptor model, provided by Hanney and colleagues in 
their extensive review on the subject, integrates and builds on many of these 
models and theories (3). With the ‘two-communities’ theory in mind, it focuses on 
the policy-makers as receptors of information, as they ultimately make the final 
decisions. Networks and mechanisms must be created at appropriate interfaces 
between these receptors and the current stock of knowledge, allowing research 
findings to enter the complex policy process. By increasing the “permeability” of 
the interface, research findings are more likely to be utilized. 
 
It is unclear to what extent these models can be applied to developing countries, 
as most of the above theory and literature is based on developed countries. Still, 
these models provide a good starting framework. Several of these models have 
already been used to understand how technical information is used in policy 
decision-making specifically for Africa (28). One can now also see how the 
present study focused on a specific point of view in this complex process with a 
particular interpretation of the meaning of research utilization. The findings that 





Previous findings on policy-makers’ perceptions 
Two systematic reviews have been carried out on this subject looking at the 
factors influencing the utilization of research findings by policy-makers. From 
these reviews, common concepts are emerging. The most common factors 
include: interactions and personal contact between researchers and policy-
makers, timeliness and relevance of the research findings, presentation of the 
research findings (specifically, the inclusion of summaries with clear 
recommendations), trust issues between researchers and policy-makers, and 
power and budget struggles (15, 16). 
 
When comparing the factors that emerged in the few studies from developing 
countries covered in the systematic reviews (40-43) with those from developed 
countries, many similarities are apparent, however some differences exist. As in 
developed countries, personal contact and interactions between researchers and 
policy-makers, timeliness and relevance of the research findings, and trust issues 
between the researchers and policy-makers were all common in developing 
countries. The inclusions of summaries with clear recommendations, and power 
and budget struggles also each emerged in one of the studies from developing 
countries. In contrast to the developed countries, political instability or high 
turnover rate of staff was also a common factor emerging in these countries. 
Policy-makers’ negative attitudes towards research findings and their lack of 
skills and expertise emerged as important factors decreasing the prospects of 
research utilization in one of these developing countries (43). 
 
In a more recent study involving four developing countries (44) – two of which 
were African – these negative attitudes towards research findings emerged as a 
factor in the interviews that took place with researchers. From the policy-makers’ 
perspective, lack of collaboration and formal communication channels also 
emerged as factors, as did: access to information, lack of a central source of 
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research outputs, the quality of research, political influences and the format of 
the research findings. 
 
Pharmacy and therapeutics committees in industrialized countries, and 
commissions that develop EMLs in developing countries make similar types of 
decisions. While not exactly the same concept, drug formularies serve many of 
the same purposes as EMLs: they are policies intended to guide the use of 
medicines. Important organizational bodies in the United States such as the 
Academy of Managed Care have promoted process guidelines for submissions 
to these committees for the specific purpose of improving the “timeliness, scope, 
quality, and relevance of the information available” so that the policy-makers can 
make more informed decisions (45). Drug formulary decisions have been widely 
studied with regard to evidence-based decisions, especially the use of 
pharmacoeconomics and cost-effectiveness analyses (see for example (46-48)). 
The use of these information sources has been regarded as non-systematic and 
varied (49). Examples of factors emerging from one study that focused on the 
policy-makers include: timeliness of studies, lack of information on potential cost 
offsets accruing to the hospital, lack of independent sponsorship, and inadequate 
expertise in economic evaluation (47). While these studies are interesting for 
comparison due to the similar types of decisions these policy-makers had to 
make, the contextual factors surrounding these groups are extremely different 
considering the differences in health care systems and economic situations. As a 
recent case study discovered while exploring the implementation of a 
randomized controlled trial on the use of magnesium sulphate to treat pre-
eclampsia in twelve countries, there are often significant differences in the 
importance of factors inhibiting implementation of research findings across 






CHAPTER III – METHODOLOGY 
 
Methods for studying the transfer of research to policy 
Different research methods are useful for analyzing different issues surrounding 
the transfer of research to policy and practice. In the literature, several methods 
have been employed and recommended to answer questions concerning the 
utilization of research findings in policy decisions (3, 38). These methods include: 
in-depth interviews, document analyses, group discussions, direct observation 
and questionnaires.  
 
In-depth interviews 
Whether it is free flowing and unstructured, or structured and open-ended, by 
telephone or face-to-face, an in-depth interview is one of the most important and 
widely used methods in the qualitative tradition, and the most often used in this 
field of research (3, 15, 16). From the first systematic review examining health 
policy-makers utilization of research findings, it is clear that assessments of the 
use of research findings are largely qualitative in nature. Of the 24 relevant 
studies identified, interviews formed the bulk of the research, with questionnaires 
representing a smaller input (16). Interviews allow the researcher to explore in 
great depth the topics as seen from the viewpoint of the interviewee, serving to 
“obtain descriptions of the lived world of the interviewees with respect to 
interpretations of the meaning of the described phenomena” (51). It has also 
been suggested that interviewing is ideal for mapping out the information transfer 
processes and the networking between decision-makers and informants (3). 
 
It is important to recognize that interviews do not measure behavior; interviews 
will not answer questions about what a person does. Instead, they tell us what 
people say, and more specifically what people say in the context of an interview. 
Asking policy-makers about their utilization of research findings cannot give a 
valid conclusion about the number of times policy-makers used research 
findings; instead it indicates the policy-maker’s perceptions of using research. 
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This limitation does not imply that an interview serves little purpose or is invalid. 
Instead, it reminds us that interviews are measuring accounts as opposed to 
objective reports on behavior (52). If trying to understand how a person perceives 
a situation, the technique is highly useful. If trying to understand how a person 
actually acts in a situation, other methods should probably be employed. It also 
deserves mention that the information obtained from interviews will be limited by 
who is being interviewed. One cannot make assumptions about what researchers 
think about pushing their findings on policy-makers by asking this question to 
policy-makers. In fact, even the extent to which one can generalize the findings 
to other policy-makers is often unwarranted in qualitative work. 
 
Document analyses 
Using existing documentation to supply information on a research topic is often 
considered an efficient use of resources. In this field of research this method has 
been used on its own (see for example (50)), or in conjunction with interviews (3). 
Used in such a way it provides opportunities for validating responses and 
triangulating the data (53). Often used in case-study designs, documentary 
sources can supply useful background information on past decisions or the 
processes that lead to these decisions. Through minutes of meetings or 
submissions to groups of decision-makers one can actually see the information 
that has been exchanged between researchers and policy-makers. Document 
analyses may not however be able to explain to what extent such information 
was considered, if it all. In addition, it is possible that not all relevant documents 
are supplied or the information ever recorded, leading to selective retrieval of 
information and threatening the reliability of the data (52). That said, a document 
analysis is one of the most common methods used in this field of research (3), 
especially as a supplementary source of information, most probably because it 
helps explain and understand the often complex processes involved in health 
policy formation. The first systematic review on this topic in fact recommends that 





Another type of interview available to researchers in this field is the group 
discussion. This could be in the form of consensus panels, focus group 
discussions, natural group discussions, or community interviews (52). Group 
discussions are useful for accessing general opinions as opposed to the opinion 
of individuals. While not the most common method in this field, group interviews 
have been used, especially focus group discussion (9, 54, 55). Compared to one-
on-one interviews, group discussions will give the researcher access to 
interaction between subjects, providing a more ‘natural’ setting for subjects (52), 
something that could be important when dealing with groups of policy-makers 
that collectively make policy-decisions. This interaction among respondents has 
also been shown to stimulate new ideas and thoughts and can therefore provide 
additional information to in-depth interviews (56). Selection of group members is 
essential for effective group interviews (57), and has been a limitation in studies 
in this field (see for example (9)). Threats to the validity of group interviews 
include social desirability, low levels of trust, face-politeness needs, researcher 
bias, and deception (56). These concerns must be taken into account when 
implementing this method. 
 
Direct observation 
This method can be an effective way of measuring policy-makers’ actual use of 
research organizations as information resources (38). By observing decision-
making in action, the researcher can gain access to the actual behavior of the 
subjects. It is also effective for analyzing how individuals or groups function in 
their natural setting. Observation helps the researcher to “understand what is 
going on in a particular context and to provide clues and pointers to other layers 
of reality” (58). It should be noted that the presence of the researcher in this 
particular setting might affect the way policy-makers act. In this particular study 
topic the involvement of a researcher at a meeting of decision-makers might not 
be desired, as decision-makers’ self-presentation might influence them to act in a 
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way to impress the research team. When using this method, the researcher 
should be aware of this issue and not assume that what is necessarily observed 
when present is the same as when not present. 
 
Questionnaires and surveys 
Qualitative questionnaires allow a standard set of research questions to be asked 
of a sample of researchers or policy-makers. This technique allows for 
comparisons within and between subjects as well as the scaling and rating of the 
amount of utilization of research findings in decision-making. Unfortunately, such 
comparisons often require larger samples than might be available. When 
studying elites such as key policy-makers in government organizations, the 
likelihood of accessing enough subjects to obtain statistically relevant 
comparisons may therefore be unlikely. That said, several studies on this topic, 
most notably from North America and the UK, have been successful in using 
postal and telephone questionnaires, many with relatively high participation rates 
(13, 14, 59-61). These types of studies can provide highly reliable information 
about the way many policy-makers act towards research findings. These studies 
can however be limited in the new insights that are gained, and so 
complementary qualitative methods, such as inclusion of open-ended questions, 
is considered useful (59-61). 
 
Using a qualitative design 
As discussed above, the methodologies in health policy research can range from 
strictly qualitative in-depth interviews to quantitative surveys of policy-maker 
behaviour; from grounded theory, inductive exploratory research to the direct 
testing of theories and models of research utilization formulated by leading 
researchers in the field. In looking at previous knowledge utilization studies, it is 
apparent that this field of research is dominated by qualitative designs (3, 15, 
16). Using qualitative research methods in health research has several 
advantages, including the ability to study interactions between different actors in 
the public health system (62). Despite this usefulness, it can cause sceptics of 
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these methods to question the validity, reliability, and generalizability of the 
findings – the ‘science’ behind the methods. Concerns often arise due to the fact 
that subjectivity often enters qualitative work – in fact it is sometimes a crucial 
aspect of the research. It is important nonetheless to demonstrate that the results 
of the study are valid and not merely anecdotal information recorded by the 
researcher. It has been argued that qualitative research must find an important 
balance between creativity and science and this can be done by sticking rigidly to 
the research procedures and maintaining an attitude of scepticism (63). 
 
Reflexivity involves an awareness of one’s preconceptions, and preferably 
sharing or declaring these preconceptions at the beginning of the study. It is an 
important aspect of qualitative research and is closely related to the validity of the 
study (64). Searching for deviant cases to the emerging theories is another 
important tool for validation (52). Triangulation, or “the combination of two or 
more theories, data sources, methods, or investigators in the study of a single 
phenomenon” (65), is often used to improve validity. When the same findings 
come from more than one source, there is increased likelihood that the 
information is valid. Researchers may also want to use respondent validation; 
giving feedback to the respondents to cross-check the data obtained (52). 
 
Qualitative research often discusses using exploratory methods, and so it may be 
asked how reliable the work is; how likely is it that the same findings would be 
found if performed by a different researcher? This reliability can be improved by 
sticking to protocol guidelines, and by being systematic and transparent in all 
stages of the research. This includes audio recording interviews, “carefully” 
transcribing these recordings, using standardized methods for field-notes, and 
presenting in-depth extracts of the data in the final report (58). Having two 
researchers simultaneously analyze the data is also useful. 
 
Qualitative research does not usually focus on generalization or discovering 
information that can be directly applied to a larger population or different 
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populations. Instead, it can be used as a way of sensitizing readers to new 
thoughts or concepts or to perform what has been called “conceptual 
generalization” (52). That is, the concepts or types of relationships that emerge 
can often be transferred, while specific facts cannot. The extent to which these 
concepts and relationships are transferred is highly dependent on the particular 
nature of the study. It is therefore important to provide appropriate contextual 
factors to the reader to allow him or her determine transferability to other settings 
(64). All these points must be taken into consideration when implementing the 
research protocol and throughout analysis and interpretation of the findings. 
 
Study design 
The present research implemented a qualitative case study design using a 
phenomenological approach to the analysis. The study did not attempt to test any 
of the models or theories of research utilization discussed above. Questions such 
as “how often” or “how many times” researchers used research findings were not 
specifically studied. The research did not attempt to explicitly measure in which 
situations policy-makers utilized research findings and in which situations they 
did not; the study did not measure actual behavior. Instead, it aimed to 
inductively explore the phenomenon of research utilization as lived and 
experienced by health policy-makers. Qualitative research is “ideal for questions 
that require an answer about understanding participants’ views, or for questions 
that address the meaning given to phenomena” (52). Since the main purpose of 
this research was to identify policy-makers’ perceptions of the factors influencing 
their utilization of research findings in the decision-making process, choosing 
qualitative techniques was appropriate. Case studies provide an excellent 
opportunity to generate detailed information about a selected case or “bounded 
system” (66, 67) – in this instance: the selection and updating of Mali’s EML. As 
mentioned above, there is a need for studies taken from the user’s point of view, 
and it has been suggested that the best way to do this would be through case 
studies as they could give a better appreciation of “how research knowledge is 
used” (italics in original (38)). By focusing on a specific health policy, participants 
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in this study had the opportunity to concretely discuss their experiences in the 
policy-making process. 
 
Different qualitative designs use different theoretical approaches to analyze their 
data. Strauss and Corbin’s grounded theory is ideal for analytically developing 
theories “grounded” in the field (63), and is probably the most common in the 
literature. The author chose to use a phenomenological approach based on the 
procedure described by Giorgi (68) to analyze the present research. A 
phenomenological approach is ideal for understanding the essence of 
experiences about a phenomenon (69). This approach therefore seemed 
appropriate, as this study’s objective was to discover the essence of policy-
makers’ experiences with the utilization of research findings in the selection of 
the medicines for the national EML. By exploring their perceived reality of the 
policy process, it was possible to determine the essence of the factors 
influencing their utilization of research findings. It should also be stated that the 
systematic and specific procedure for analyzing the data described in Giorgi’s 
analysis appealed to the author. 
 
Data collection and study population 
The author traveled to Mali to implement the research protocol. Three separate 
methods were used in the study design. The majority of the data was collected 
from nineteen in-depth, semi-structured interviews. Key informants were chosen 
from the national commission that selects and updates Mali’s EML. This 
“purposeful sampling technique” results in “information-rich cases for in-depth 
study” (70). The principle investigator was provided with a list of all members of 
the commission. With the help of Diadié Maïga (DM) – an employee at the 
Direction of Pharmaceuticals and Medicines and third author in the article 
submission – members were chosen from the list, were contacted by telephone 
or in person and asked if they would be interested in participating. The order in 
which members were contacted from the list was primarily based on accessibility. 
Two members on the list had changed departments and could not be located, 
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and the few members not living in the Bamako area were not included (one 
commission member from outside the capital who was scheduled to visit Bamako 
was contacted, but was unavailable). One member of the commission who was 
available chose not to participate since the author did not have a written and 
signed letter of permission from the Ministry of Health. One health manager who 
was not on the commission was mentioned in initial interviews as having played 
a significant role in the decision-making process for this policy, and was 
recommended for participation. This person was also included in the study. 
Interviewing continued with available participants until theoretical saturation had 
been reached. 
 
A natural group discussion is a specific form of group discussion with “people 
who know each other already” (52). One such discussion was used to 
supplement the information from the interviews. It also provided the opportunity 
to observe interactions between policy-makers and present preliminary results to 
the group members for feedback, obtaining respondent validation (52). Members 
were chosen from the policy-makers who were involved in the in-depth, semi-
structured interviews. Following each interview, policy-makers were informed that 
they would potentially be asked to join this session. Many participants welcomed 
the idea, stating that they would appreciate some preliminary feedback on the 
results of the study. Knowing that many would not be able to attend due to 
conflicting schedules, all nineteen policy-makers who participated in the 
interviews were contacted twice by telephone and invited to participate in the 
discussion at a specific date and time. Only four individuals were able to 
participate in the group discussion. This included both senior staff and lower level 
civil servants. Both the author and DM facilitated the discussion. 
 
A document analysis was also performed to validate comments made by the 
participants and to analyze actual sources of information accessed by the policy-
makers. Several of these documents were provided by the Director of the 
Direction of Pharmaceuticals and Medicines and covered several updates of the 
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EML that had taken place over the last ten years. The individual who prepared 
the technical notes for the most recent updating of the commission also supplied 
relevant documents. In addition, together with the secretariat for the commission, 
the author went through and extracted all electronically stored documents saved 
by the commission on the Direction’s database. 
 
Details of the participants, the methods employed, and the way the data was 
handled is provided in the Methods section of the research article submission 
found in the next chapter. The interview guide is also provided in Appendix 1. 
 
Ethical considerations 
The protocol was to be presented to the ethical committee of the National 
Institute of Public Health, however upon arrival in Mali the author was informed 
that such a protocol did not require ethical approval. Regardless, individuals 
requested for interviews were given an informed consent form (attached as 
Appendix 2). They were informed of the main purpose of the study and what was 
required of them if they chose to participate. They were told that any information 
they provided would remain anonymous and confidential and that they could 
withdraw at any time without penalty. During transcription, points of reference 
that might identify the subject were removed and replaced with terms and 
identifiers that would preserve the anonymity of the subject. Interview transcripts, 
audio-recordings and interview notes remain with the author in a secure location 
only accessible to the author and co-investigators. 
 
Analysis 
All interviews and the group discussion were analyzed based on Giorgi’s 
phenomenological approach (68). The steps for the analysis are highlighted in 
the research article, however they are presented here in greater depth: 
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1. The author went through and read all of the interview transcripts, notes taken 
during the interviews, and summaries made from the interviews not recorded. 
This was done to gain an overall impression of the research. 
 
2. The author then went through all textual data from the interviews and identified 
all comments that appeared significant to the research and provided some 
meaning to the issue of utilizing research findings in the policy process. These 
significant statements were extracted from the text. Giorgi refers to these 
meaning units as constituents, highlighting that they are “differentiating a part in 
such a way that one is mindful of the whole.” (71). Using the Giorgi approach, 
counting the number of times similar statements occurs is not necessary, so 
redundancies were eliminated. The remaining meaning units were then 
translated into English by the author. 
 
3. The translated meaning units were then compared with each other and the 
particular context of research utilization in policy-making. The meaning units 
were then expounded. This resulted in a set of abstractions or concepts that 
each revealed something about the process of utilizing research findings in 
policy-making. Both the author and a second investigator (the author’s 
supervisor, AF) each independently performed this task, followed by a discussion 
and consensus. 
 
4. These concepts were then categorized and summarized into factors 
influencing the utilization of research findings as perceived by policy-makers. The 
author and AF also both independently performed this step. This was followed by 
discussion and consensus, after which the author returned to the extracted 
significant statements to ensure a good fit with the final factors. 
 
The analysis of the natural group discussion followed a similar process. In the 
initial stage of gaining an overall impression, the observations made during the 
discussion of interactions between participants were taken into consideration. AF 
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did not participate in the majority of the analysis of the discussion, but did 
participate in the final stage, examining how the meaning units fit with the 
emerged factors. 
 
Throughout the analysis various issues were brought up between the author and 
the second investigator, and conflicting views were discussed until consensus 
was reached. The sharing of preconceived notions was an essential part of this 
process. This critical reflection process is often referred to as bracketing and the 
bracketed ideas are referred to as epochs. This is a fundamental component in 
phenomenological research and allows the researcher to separate him/herself 
from the data. 
 
The factors that emerged from this process are provided in the article submission 
found in the next chapter. After the factors had emerged from the data, they were 
compared and analysed against those found in previous studies of research 
utilization. These factors were also analyzed with respect to previous theories of 
research utilization, outlined above. The Discussion section in the article 
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Research findings are increasingly being recognized as an important input in the 
formation of health policy. There is concern that research findings are not being utilized 
by health policy-makers to the extent that they could be. The factors influencing the 
utilization of various types of research by health policy-makers are beginning to emerge 
in the literature, however there is still little known about these factors in developing 
countries. The object of this study was to explore these factors by examining the 
implementation of a pharmaceutical policy common in developing countries; an essential 
medicines list. 
Methods 
A case study of the selection and updating of Mali’s national essential medicines list was 
undertaken using qualitative methods. In-depth semi-structured interviews and a natural 
group discussion were held with national policy-makers, most specifically members of 
the national commission that selects and updates the country’s list. The resulting text was 
analyzed using a phenomenological approach. A document analysis was also performed. 
Results 
Several factors emerged from the textual data that appear to be influencing the utilization 
of health research findings for these policy-makers. These factors include: access to 
information, relevance of the research, use of research perceived as a time consuming 
process, trust in the research, authority of those who presented their view, competency in 
research methods, priority of research in the policy process, and accountability. 
Conclusions 
Improving the transfer of research to policy will require effort on the part of researchers, 
policy-makers, and third parties. This will include: collaboration between researchers and 
policy-makers, increased production and dissemination of relevant and useful research, 
and continued and improved technical support from networks and multi-national 
organizations. Policy-makers from developing countries will then be better equipped to 
make informed decisions concerning their health policy issues. 
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Background 
Most health researchers and those who fund health research would like to believe that the 
work they produce and support is influencing practice and policy and consequently 
leading to actual improvements in health care delivery. The study of research’s influence 
on policy has had a long and rich background, from early work on the utilization of social 
science knowledge in government and public policy [1, 2], to more recent inquiries into 
the utilization of systematic reviews by policy-makers [3]. While the various models of 
policy-processes that have emerged in this field demonstrate that there are many ways in 
which research may be influencing policy [4, 5], it is widely recognized that the level of 
research utilization by policy-makers is lower than it could be [6]. The body of literature 
examining the factors influencing the utilization of research findings by policy-makers is 
increasing. From the two systematic reviews on the subject, common factors are 
emerging such as: interactions and personal contact between researchers and policy-
makers, timeliness and relevance of the research findings, the inclusion of summaries 
with clear recommendations, mistrust between researchers and policy-makers, and power 
and budget struggles [3, 7]. Most of these findings are however based on studies from 
industrialized countries, and thus more research is needed into the factors that affect the 
linkage between research and policy in developing countries. With their limited resources 
these countries have much to gain from well-informed health policies [8]. 
 
The present research focused on one specific health policy: Mali’s national essential 
medicines list (EML). In 1975 the World Health Organization (WHO) introduced the 
global concept of essential medicines with the first model EML introduced two years 
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later. Updates every two years have lead to the current 14th model list [9]. This reference 
document is usually used as a starting point for a national list, however each country 
requires additional information from monitoring and research for its specific health 
situation [10]. Like many developing countries, the West African country of Mali has a 
national EML. The Malian list does contain several medicines not present on the WHO 
model list, including an extra section for “improved traditional medicines.” The country’s 
official criteria for the selection of medicines for the list at the time of this study 
included: harmlessness, efficacy, relevance to the disease pattern, availability on the 
international market, and cost-effectiveness [11]. Since research findings have much to 
contribute to these criteria, the factors influencing their utilization, as perceived by 
policy-makers, were examined. 
Methods 
A qualitative case study approach was used for the present research. By focusing on a 
specific health policy, participants had the opportunity to concretely discuss their 
experiences in the policy-making process. After presenting the protocol to the National 
Institute of Public Health Research in Mali, the principle investigator was informed that 
written approval from the ethical committee was not necessary. 
  
Participants 
A purposive sampling technique was used by selecting key informants from the national 
commission that selects and updates Mali’s national EML. The commission is composed 
of various Ministry of Health staff including health program managers, technical 
advisors, pharmacists, as well as local medical practitioners considered experts in their 
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field and technical advisors from the WHO and the European Union. One health manager 
who was not on the commission was mentioned in initial interviews as having played a 
significant role in the decision-making process for this policy, and was recommended for 
participation. This person was also included in the study. One member of the commission 
who was available chose not to participate since the interviewer did not have a signed 
letter from the Ministry of Health. A total of nineteen policy-makers (17 men and 2 
women) took part. While there were 33 members on the commission, data saturation had 
been reached and so further interviewing was deemed unnecessary [12].  
 
Data collection 
The principle investigator (MA) conducted 19 in-depth, semi-structured interviews in 
French (33-89 minutes), between September and December 2005. The interview guide 
(see Additional file 1: Interview guide) was largely based on the draft interview schedule 
for assessing research utilization in policy-making provided by Hanney and colleagues as 
an additional file in their review of research utilization [6]. The topics discussed included: 
key informants and policy-makers in the policy-process, perceived importance of 
research findings in the decision-making process, forms of communication found to be 
useful, different ways research can be used, how well equipped the commission was in 
absorbing research findings, specific aspects of research that made it useful, 
presentation/format of research findings, the inclusion of traditional medicines on the list, 
barriers and facilitators to research utilization, and policy-makers’ recommendations of 
how to increase their utilization of research findings. 
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A natural group discussion, defined as a group interview with “people who know each 
other already” [12] was also conducted (55 minutes). All 19 interviewees were invited 
knowing that many would not attend. Four individuals participated in the group 
discussion. MA gave a short presentation of the research and discussed the preliminary 
findings. Participants were asked to comment and a group discussion of key topics 
followed, with MA and DM facilitating. A document analysis was also performed. These 
documents covered several updates of the EML that have taken place over the last 10 
years. They included the technical notes used by the commission, the documents used to 
prepare these notes, minutes from meetings, a critical analysis of the country’s EML, a 
synthesis of the decisions made, copies of emails sent to and received from contacts 
abroad, Internet printouts, and various other relevant documents. 
 
All but four of the interviews and the natural group discussion were recorded and 
transcribed by MA, who also took in-depth notes throughout each session. For those that 
were not recorded – at the requests of the interviewees – MA went over the in-depth 
notes and produced a detailed summary the same day as the session. 
 
Analysis 
All interviews were analyzed based on Giorgi’s phenomenological approach [13]. The 
analysis followed the following steps: (i) going over all the textual data to gain an overall 
impression, by MA; (ii) identifying all comments that appeared significant to the 
research, extracting these meaning units and translating them into English, by MA; (iii) 
independent abstracting of the meaning units by MA and AF, followed by discussion and 
consensus; (iv) independent categorization and summarization of abstractions into factors 
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influencing the utilization of research findings as perceived by policy-makers, by MA 
and AF, followed by discussion and consensus; and finally (v) returning to the extracted 
text to ensure a good fit with the final factors, by MA. The analysis of the group 
discussion followed a similar process, however AF only participated in step (v). The 
document analysis was used to validate statements made in the interviews and to examine 
the information presented to the commission. Throughout the analysis preconceptions 
were shared and critically reflected on between the investigators.  
Results  
The factors that emerged from the interviews and group discussion are presented here. 
The embedded quotations were translated from French by MA and are included here for 
illustrative purposes. 
Access to information 
“The big ticket, at least in the case of Mali, and certainly the case for most African 
countries where we have problems with quality human resources and regular access to 
scientific information is the means to allow these people to keep themselves permanently 
informed.” 
 
Access to information was discussed in great depth, often accompanied by the statement 
“we do not have the means”. While the Internet and various online resources were 
mentioned as useful in improving access to research, many of the policy-makers are still 
not connected and those who are have limited, if any, access to paid sites. Even at the 
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local level it was perceived that the transfer of information from research institutions to 
policy-makers is poor. 
 
Limited capacity in accessing research findings was also stated as hindering its use. If a 
policy-maker has extra staff or is a supervisor of students who can search, gather, and 
compile the information, research findings are more likely to get used. The availability of 
key texts that supply such information was also seen as facilitating the utilization of 
research findings. In addition, the more contacts available to policy-makers – be they 
local experts or international organizations abroad – the greater access policy-makers felt 
they had to research findings. 
 
Language was discussed as well. Mali’s official language is French and while policy-
makers agreed that “the scientific language” could largely be understood even without a 
solid grasp of English, many also stated that this was a problem. “It is a serious 
handicap, serious.” Policy-makers depend greatly on information available to them in 
French, and this was felt to be limiting. “If I understood English… I am sure that I could 
do so much more for everyone.” 
Relevance of research findings 
It was stated in the group discussion that most research that is produced is irrelevant to 
policy-making. Researchers were described as “doing activities to survive,” and not 
necessarily to answer questions that need answering. It was proposed that collaboration 
between researchers and policy-makers could allow policy-makers to give some input 
into the research process. 
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Time consuming process 
When discussing the presentation of research findings, interviewees indicated that a 
lengthy report or publication would not be read, and recommended that researchers 
provide short and concise documents. In fact, policy-makers stated that research 
utilization is already a lengthy and time-consuming process. Even if research is 
considered important, it still requires a significant amount of time to search, locate, 
access and review the relevant literature. “It demands sacrifice.” 
Trust in the research 
Policy-makers want information they can trust. Those who were able to commission 
research found this to be important in allowing them to utilize the findings. This was not 
only because it improved the relevance of the research, but also because it increased how 
much the policy-makers trusted the research. As one policy-maker metaphorically stated: 
“If I told you, behind that door there is a cup of tea with sugar and then I give you a cup 
of tea with sugar here. Which tea can you appreciate? What is outside is not bad, but 
what is in my hand, that, I can defend.” 
 
While no particular form of presentation was stated as being more useful than another, 
policy-makers indicated that reports should be short (discussed above), and that they 
would like sections dedicated to methodologies and references. These are considered 
necessary for determining the quality of the research and therefore whether or not it can 
be trusted. Policy-makers indicated that their confidence in journals that publish research 
findings is also relevant. “If it’s in the Lancet or the New England Journal of Medicine, 
or Science, well, right away we jump on it.” Similarly, research that is supplied by a 
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trusted international organization is more likely to get used. “If [the research] comes 
from the WHO, we know it isn’t just taken from anywhere… we have confidence in the 
source.” 
Authority of those who present their view 
Some interviewees recognized that there is often an uncritical reliance on specialists. 
Comments made by respected individuals or those deemed extremely knowledgeable in 
the subject area are highly influential. “We are often not critical. As a decision-maker we 
should be going into greater depth… a specialist comes in and we simply say, we’re 
listening… and we write it down. There is no way to contradict, or at least construct 
contradictory information vis-à-vis the specialist.” This could result in either a decrease 
or an increase in research utilization. For example, it was stated that a respected professor 
was useful as leverage in promoting research findings to other members of the 
commission. At the same time, respected individuals might not be basing their 
recommendations on research. One policy-maker stated that cultural factors might be at 
play here; as a “verbal society” many policy-makers prefer verbal reports to 
documentation, and place more importance on information that is provided to them by 
individuals who are highly respected, than documents from a removed source. 
Competency in research methods 
Some policy-makers were involved in research studies or programs. Having researchers 
act as policy-makers was seen as a facilitator to research utilization, and not only because 
they can provide research findings or act as leverage, but also because they are able to 
provide a “veritable training in research methods”. Such training was considered 
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important in improving other policy-makers’ competencies in research methods and their 
ability to understand research presented. While most felt that the commission members 
were highly qualified, several agreed that more training in research methods would make 
it easier and further motivate them to utilize research findings. “There are always 
nuances in scientific research findings… in order to adapt research findings to make an 
applicable decision, and certainly when it comes to medicines, I believe the commission 
members must have a level of qualification sufficiently high in order to effectively exploit 
the conclusions.” However, one policy-maker who participated in such a training session, 
claimed to have gained little from the experience. Still others stated that if training is to 
be provided, incentives to continue working as a low-salaried civil servant must also be 
included. It was also brought up that increased competency in research methods would 
not only improve policy-makers’ ability to understand the research, but it would also 
increase the importance they place on research and their motivation to use it. 
Priority/importance of research in making the policy 
When asked about the importance of research findings in the decision-making process, 
policy-makers all stated that, while research is important, other information sources often 
take precedence. Influence on the policy from higher and lower levels in the health care 
system, such as political will or demands from patients and clinicians tend to be 
prioritized over research findings. 
 
On the other hand, several policy-makers discussed the fact that this particular policy is 
highly technical and they could not understand how one could not use research in the 
decision-making process. “This is above all else a technical job, scientific. Its basis is 
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science.” The extent to which policy-makers value research findings in the policy process 
will influence how much it is utilized. 
Accountability 
There was some confusion over whose role it is to look up information. Medical 
professionals and specialists on the commission felt that the technicians in the Ministry of 
Health were in the best position to access and compile research findings for 
consideration, while some of these individuals felt that specialists should be supplying 
relevant findings from their field. Having a specific person or group of persons delegated 
to search and compile relevant research findings for the policy question at hand was 
perceived to be extremely helpful. “You cannot place the responsibility on each person. If 
you do that it is not going to get done. You have to have a specific group whose job it is 
to get the information.” 
Discussion 
By analyzing the selection and updating of Mali’s EML, this case study discovered 
several factors that influence the utilization of research findings by health policy-makers 
in a developing country. Like most studies in this field, this research used qualitative 
methods with the majority of the data coming from in-depth interviews [6, 7, 14]. 
Qualitative methods were chosen as they are “ideal for questions that require an answer 
about understanding participants’ views” [12]. In using such methods, concerns about the 
validity of the results can arise. It is important to recognize that this study did not 
measure policy-makers’ actual behavior, nor did it measure objective factors that 
influence their utilization of research findings. Instead, the findings represent policy-
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makers’ perceptions of these factors. In addition, this study did not take into account 
researchers’ perceptions of these issues, as has been explored elsewhere [15-19]. 
 
By using three separate data acquisition methods, the validity of the findings was 
improved [20]. In addition to supplementing the information from the in-depth 
interviews, the natural group discussion provided an opportunity to give feedback to 
participants, allowing for respondent validation [12]. The selection and number of group 
members is important for effective group discussions [21], but was a limitation in this 
study. The results of the document analysis helped to validate participants’ statements 
regarding sources and documents that were accessed. This analysis is limited however 
because it not known how much consideration, if any, such documents were allotted. The 
reliability of the results was improved through the use of independent investigators in 
several stages of the data analysis [22]. There are limitations in the extent to which we 
can generalize the findings of this study to other policy-makers and other developing 
countries, due to the exploratory nature of this study and the fact that it examined only 
one aspect of policy-making in one particular setting. 
 
Two factors emerged from this study that are unique in the literature: the authority of 
those who present their view and the issue of accountability. These issues may be due to 
the specific nature of these policy-makers or their cultural setting, and so it is unclear to 
what extent these factors would be important in other settings. Several of the factors 
emerging from this study are common in the literature, including: relevance of research 
findings, trust in the research, and competency or skills of the policy-makers [3, 7]. 
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Training policy-makers in research methods and sensitizing them to the usefulness of 
research findings in the policy process has also been recommended in previous studies 
[18, 23, 24]. Access to information, an important factor in this study, also emerged as a 
barrier to research utilization in a recent study involving four developing countries – two 
of which were African [15]. This study also indicated that the lack of value policy-
makers placed on research findings was inhibiting its uptake. These negative attitudes 
towards research have also emerged as a barrier to research utilization in a study 
conducted in Mexico by Trostle and colleagues [18]. The present study seems to support 
this finding, and at the same time indicates that if research is considered important in the 
policy process it may also act as a facilitator to its utilization. 
 
The presentation format of research findings has been mentioned in the literature as a 
potential facilitator of research utilization, for example by including summaries with clear 
recommendations [18]. In developed countries, this has been studied further, analyzing 
whether a specific format such as the “1:3:25” format (1-page take-home messages; 3-
page executive summary; 25-page report) would facilitate the utilization of research 
findings [3]. Policy-makers in the present study did not believe that a specific format 
would affect whether or not they would use the research findings. The general consensus 
was that the report should be short, while supplying enough information to allow them to 
evaluate the quality of the research (by including the methodology and references). 
 
The relative importance of research findings in the policy-process is a complex issue. For 
example: Mali is one of the few countries in Africa with traditional medicines on its 
 47
EML. In discussing one of these ‘improved traditional medicines,” one policy-maker 
mentioned having knowledge of, and considering, a study that had concluded that the 
medicine in question, while somewhat effective, was not the most effective. For that 
policy-maker, political will and community values were more important in the final 
decision. While the authors might not necessarily agree with the decision made, there is 
potentially nothing wrong with policies that do not follow research recommendations, as 
long as the research is considered. According to the conceptual approach to the definition 
of “research utilization” from Nutley and colleagues’ adapted from Weiss, research that 
affects policy-makers understanding of a situation – even if the final decision does not 
follow directly from researchers’ recommendations – is still being utilized [25]. Other 
influences such as local values and needs are recognized as important inputs into policy 
[4]. It is, after all, policy-makers who make policy, not researchers. In this example then, 
even though research was considered less important, it was still used in the policy 
process. If several factors are working together however, the utilization of research is 
likely not to occur at all. If using research findings does not take precedence and is 
already perceived as a time-consuming task in a country where capacity to access this 
information is low, and no one is quite sure who is responsible to get the information, 
then chances are the research will not be read or considered, let alone influence the 
decisions of the policy-maker. 
 
Policy-makers’ belief that searching, accessing and reviewing research findings is highly 
time consuming is perhaps a good argument for the increased production, promotion and 
dissemination of systematic reviews. Systematic reviews are increasingly recognized as 
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offering many advantages to the target audience [26], including the fact that they lead to a 
more efficient use of time [3]. No policy-makers mentioned having utilized information 
from systematic reviews, and most seemed unaware of their existence. Organizations 
such as the Cochrane Collaboration and the National Institute for Health and Clinical 
Excellence of the UK are currently leading the way in providing systematic reviews for 
medical practice. Studies have begun looking at how to improve their usefulness for 
health care managers and policy makers [3]. Interestingly, the Essential Medicines 
Department of the WHO actually re-introduced amodiaquine in the treatment of malaria 
following the publication of a systematic review from the Cochrane Collaboration 
indicating its safety and effectiveness compared with chloroquine [27]. Much work is still 
needed before systematic reviews are utilized in common practice in the formulation of 
policy at national levels, especially in developing countries. 
 
Policy-makers in the present study stated that it was extremely helpful having trusted 
networks such as multi-national organizations supply information relevant to their 
decision-making. The fact that the WHO initiated the EML policy and supplied the 
commission with a model list was felt by one policy-maker to be the main reason why 
most of the medicines on the national EML were chosen based on evidence. These multi-
national organizations can play an important role as knowledge brokers in helping policy-
makers in developing countries make informed-decisions through continued and 
increased technical support [28, 29]. 
 
Perhaps the most prevalent theory discussed in the literature on this topic is the “two-
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communities theory” developed by Caplan and colleagues. It highlights the fact that 
health researchers and policy-makers have two competing world views [2]. Increased 
collaboration and personal contact between researchers and policy-makers have been 
proposed and studied as solutions to the problems related this issue [30]. While these 
concepts were discussed in the interviews, the authors agreed that they did not emerge as 
factors per se. They were seen as indirect influences. Increased collaboration and 
personal contact between researchers and policy-makers could lead to increased access to 
information, improve policy-makers’ trust in the research, enhance their understanding 
of, and competency in, research methods, and allow them to influence the research and 
make it more relevant to their own needs. This last point, while seemingly good for 
policy-makers, can pose potential problems to the objectivity and quality of research 
produced [7, 31].  
 
With the limited number of studies from developing countries on this topic, further 
research seems necessary. The factors emerging from this study, including those that are 
not common in the literature, warrant further investigation and should be considered in 
the planning of strategies to bridge the gap between research findings and policy-making. 
How best to advocate the critical evaluation of all information sources, and the delegation 
of the specific task to search for research findings, as suggested by the policy-makers, 
remains unresolved. Different approaches to analyzing these issues will be important for 
future research. The present study analyzed the utilization of research in implementing 
the details of a policy – the selection of specific medicines for an EML – considered an 
important stage of influence in policy-formulation [4]. The types of factors influencing 
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the utilization of research findings likely differs in other levels of policy-making – for 
example the decision to have an EML in the first place. Getting an overall analysis of all 
levels of policy-formulation will be important for future research. Finally, it will be 
important to continue examining the effectiveness of strategies used to improve the 
uptake of research findings, such as case studies of collaborative research projects 
between researchers and policy-makers and analyses of the use of knowledge brokers in 
bridging these two communities. 
Conclusions  
In order to determine the factors influencing policy makers’ utilization of research 
findings in a developing country, this qualitative case study examined health policy-
makers’ experiences in the selection and updating of Mali’s EML. Due to the nature of 
the methods used, there are limitations to how far these factors can be generalized to 
other settings or other health policies. That said, many of the factors that emerged in this 
research have been found in similar studies in the literature. These factors support the 
issues related to the two-communities theory common in the literature, and highlight the 
importance of bridging these communities in order to improve the uptake of research 
findings. 
 
Improving the transfer of research to policy will require effort on the part of policy-
makers, the research community, and third parties. Policy-makers are likely to increase 
their utilization of research findings if their competency in research methods is improved 
and the importance they place on research findings in the policy-making process is 
increased. Providing these policy-makers with information they feel they can trust is also 
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essential. Researchers can also improve the uptake of their research by making efforts to 
investigate policy-relevant issues. Increased collaboration between researchers and 
policy-makers and continued and improved technical support from various networks and 
multi-national organizations will put policy-makers in a better position to make more 
informed decisions so that the best health policies may be implemented in settings where 
the population potentially has the most to gain. 
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CHAPTER V – COMMENTS AND CONCLUSIONS 
 
Several issues and concepts warrant further discussion and elaboration, which 
could not be undertaken in the research article due to the limitations in space 
dictated by scientific journals. These issues will now be addressed. 
 
Diversions from the protocol 
In all fieldwork, situations arise, circumstances change, issues previously 
unconsidered by the researcher are illuminated, and diversions or adjustments to 
the protocol must be made. Such was the case in this study as well. The 
interview guide changed from its original version in the protocol upon arrival in 
Mali after a review of relevant documentation (the interview guide found in 
Appendix 1 is the updated guide actually used in the field). As the interview 
process progressed, the interviews were also further adjusted to elaborate on 
issues discussed in previous interviews. This is in fact normal if not essential in 
qualitative interviewing, where such a strategy allows emerging concepts to be 
further explored (72). 
 
This research originally had the ambitious goal of interviewing researchers or 
“information providers,” in addition to the policy-makers. This would have 
contributed to the data by providing information about how policy-makers interact 
with providers of research findings and it would have potentially allowed for an 
exploration of researchers’ perceptions of disseminating or ‘pushing’ research 
findings to the policy-makers. During the exploration and mapping out of the 
information transfer process, where other key policy-makers and informants were 
identified, very few specific individuals were highlighted as “information 
providers”. For this reason, as well as time, budget, and feasibility issues, these 




As mentioned above, while the natural group discussion was helpful in 
supplementing information and allowed for observation of interactions between 
policy-makers, the limited number of individuals who were able to participate in 
the natural group discussion, and the fact that the author was unable to control 
for which policy-makers would participate, were weaknesses of this study. It 
would also have been advantageous to have more than one group discussion in 
order to better to triangulate the data, however this was unfortunately impossible. 
Organizing group interviews in this context was, as anticipated, extremely difficult 
due to the scheduling of policy-makers. For this reason, this study had originally 
intended on performing some direct observation of the updating of the country’s 
EML, as policymakers would all be available in one setting. This would have 
provided direct insight into how the selection committee functions as a group, 
and allowed the author to observe first-hand the decision-making process. Mali 
usually updates its EML towards the end of December every two years, and 
organizers of the commission welcomed the idea when it was presented by the 
author. Unfortunately, although the EML was due to be updated, the scheduling 
of the commission meetings were delayed, and the process had not yet begun 
when the author was required to leave the field at the end of December. Direct 
observation was therefore not possible. The author recommends that such a 
component of a study be considered in future research, as involvement in the 
process would be highly enlightening. Researchers would need to be aware that 
the policy-makers might act differently due to the presence of the researcher, in 
attempts to present themselves in a good light. Such a presentation would 
however also be interesting to observe, as it would give insights into policy-
makers’ perceptions of what the research team felt they should do. 
 
It should also be stated that the author originally went into the field with the idea 
of using grounded theory as an approach to analyzing the data. Early in the data 
collection it became clear that this was not the approach the author was in fact 
using. Upon further exploration of analytical approaches, it was decided that the 
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analysis would use phenomenology as its foundation, and the analysis 
proceeded as described above. 
 
Uncommon factors 
Of those factors that were not common in the systematic reviews, some have 
begun to emerge in the limited literature on this topic in developing countries and 
were mentioned above. The factor of “access to information” that appeared in 
this study has emerged in the recent study from four developing countries (44). 
This concept encompasses many contextual factors influencing the utilization of 
research findings – in the present study this includes: capacity, electronic access, 
and language issues. This factor is likely highly related to financial issues, and 
therefore may be a concept only prevalent in economically strained settings, 
explaining its lack of commonality in the systematic reviews.  
 
Policy-makers’ perceptions that utilizing research findings was a time consuming 
task is perhaps not surprising, however it is interesting that this was perceived as 
a factor influencing the utilization of research findings. This was a difficult 
concept to grasp during the analysis of the data since “time-constraints” emerged 
in interviews, however it was unclear to what extent it might decrease the 
prospects for utilizing research findings, as all decision-making is usually 
constrained within some time-framework. Upon further analysis, it became clear 
that utilizing research findings was perceived as highly time-consuming. The 
important thing to recognize with this factor is that it may exacerbate other factors 
already in place. If policy-makers have limited access to research findings with 
limited capacity to search and compile the information, time constraints may 
dictate that policy-makers will not be able to utilize research findings, even if they 
are highly valued and considered extremely important in the policy-making 
process. 
 
The factor corresponding to the uncritical reliance on individuals who held certain 
positions of authority is unique in the literature, however it does relate to other 
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important concepts. Trust is fundamental here. Just as the confidence in journals 
and international organizations increased the prospects of utilizing their research 
findings, the confidence given to persons in authority increased the likelihood of 
using their information. As identified by many of the policy-makers, the ability to 
critically assess information presented regardless of one’s expertise in the 
subject is essential.  
 
Accountability is an issue in all decision-making. It is in fact related to why the 
author chose to conduct the present study: if researchers and research funders 
are to be accountable for the massive amounts of financial resources they spend 
on health research, they may need to justify such spending by improving the 
transfer of information from research to policy (3). As the World Bank states: 
“accountability requires clear rules and expectations, transparent information to 
monitor performance, and incentives and enforcement mechanisms that reward 
success and address failure” (73). It is highly likely that the first two points of this 
definition – clear rules and expectations – may be the principle reasons why 
accountability is a factor influencing the utilization of research findings. As was 
presented in the Results section of the research article, if it is unclear whose 
responsibility it is to provide this information, it increases the likelihood of it not 
being provided at all. For group policy-making, specifically delegating the task of 
searching, accessing, reviewing, and providing research findings to a particular 
group or individual may be an effective way of dealing with such a problem. How 
to advocate such a strategy is less clear and warrants further investigation. 
 
Implications 
When analyzing the findings from this study, it is important to take into 
consideration the particular positioning of this research and the policy-making 
process it examined. The type of policy-maker, the particular stage of the policy-
process, and the definition of utilization used in this study are all relevant to the 
inferences one can make from the research findings. With that in mind, it is of 
interest to see how the findings from this research relate to the various models 
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and theories described in the background section of this thesis. The 
incrementalist models are recognizable in these findings since there were several 
inputs that played critical roles in the final decisions for these policy-makers. 
Similarly, the network models are equally relevant, since the various relationships 
policy-makers held with various information providers influenced both the access 
to research findings and the trust placed on the information provided. Kingdon’s 
streams model is perhaps less relevant considering the fact that this model 
focuses on policy agenda-setting, and the present research focused more on the 
specific decisions required for the implementation of a policy. 
 
As stated in the article, several of the factors from this study also correspond well 
with the two-communities theory of research utilization, namely: trust in the 
research, competency in research methods, and relevance of research findings. 
Collaboration and increased personal contact between researchers and policy-
makers is by far the most often discussed strategy for dealing with this issue and 
has been discussed in the article presented here. An important difficulty with this 
recommendation has been mentioned in previous discussions. While perhaps not 
entirely relevant to the particular context of the current study, this issue still 
deserves mention, and has been eloquently stated by Innvaer in the first 
systematic review on this topic: 
 
“If what is required for research to be used is that researchers do 
what the policy-maker wants them to do, then research may fail to 
fulfill one of its most important functions, namely to be objective, 
reliable and unbiased” (16).  
 
Increasing the collaboration between researchers and policy-makers may 
therefore get research into policy-making, however it will be important for 
researchers to preserve a certain amount of autonomy if these essential 
functions are to be upheld. In addition, this systematic review indicates that 
increasing the personal contact between researchers and policy-makers may 
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also increase the inappropriate utilization of research, in the symbolic, selective 
sense of the word. The interfaces and receptors approach to looking at research 
utilization has been described as being able to address this particular “paradox” 
(3). The model suggests improving the permeability of the interface between 
available knowledge and the policy-making process through several avenues, 
including the development of links with researchers on a long-term basis, and 
training of policy-makers in the value and need for systematic reviews. Such 
techniques could therefore improve policy-makers’ appropriate use and analysis 
of available evidence. This research arguably supports such an approach. The 
findings suggest that the benefits of collaboration and personal contact may be 
as much due to access, trust, and competency as they are to the relevance of 
research findings. The involvement of multi-national organizations, such as the 
WHO was therefore recommended. These organizations could aid in increasing 
the access to research findings and the improvement of policy-makers’ expertise 
and skills. In fact, WHO has recently launched an initiative in several developing 
countries in Asia and Africa with the aim of “providing a bridge between research 
and policy”: the Evidence Informed Policy Network (EVIPNet) (74). 
 
As stated in the opening words to this thesis, the most often recommendation 
made in research studies is for more research. The reader should therefore have 
been expecting the recommendation for further research when it appeared in the 
research article above. There is in fact a need for a better understanding of how 
to improve the organization of research efforts in order to increase the likelihood 
of it influencing policy and contributing to improvements in health care delivery 
(3). Continued research on this issue in a developing country context is therefore 
important. It will be necessary to look at the problem from various angles in the 
policy process, examining different types of utilization, and the various strategies 
used to improve the situation. In doing so, a solid knowledge base can be built, 
allowing appropriate and effective strategies to be made to improve the transfer 




Research findings are increasingly recognized as an important and critical input 
for the formation of health policy, yet it has become evident that these findings 
are not being utilized to the extent that they could be. Policy-making and the 
influence research findings can have on the decisions involved is a complex 
process. There are several angles one can therefore take to study the various 
problems involved in the know-do gap. With a limited number of studies focusing 
on developing countries, there is a great need for further investigation into what 
factors are influencing the utilization of research findings by health policy-makers 
in such a setting. This qualitative case study therefore examined the updating 
and selection of the medicines on Mali’s national EML in order to address this 
question. Given the particular positioning the author chose to take in the policy-
process, the potential methodologies that can be used, including those found 
most often in the literature, have been compared and contrasted for their 
strengths and weaknesses in answering this research question. 
 
Using Giorgi’s phenomenological approach to analyze the data, the author has 
revealed several factors influencing the utilization of research findings that 
emerged from the interviews and natural group discussion held with policy-
makers in Mali. These factors include: policy-makers’ access to information, the 
relevance of research findings, the perception that utilizing research findings is 
time-consuming, the trust policy-makers place on research, the authority of those 
who present their view, policy-makers’ competency in research methods, the 
relative importance or priority of research findings compared with other sources 
of information in the policy-process, and the uncertainty of who is responsible or 
accountable for accessing, locating, and providing research findings to address 
the policy-decisions. 
 
These findings seem to support relevant models and theories of research 
utilization emerging in the literature. The author also provides similar 
recommendations to those given in past studies addressing this topic. There are 
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several strategies for addressing these factors, including collaborative projects 
between researchers and policy-makers, involvement of multi-national 
organizations, and the production, dissemination and focus on relevant, useful 
and appropriate research findings, such as those found in systematic reviews. 
Increased efforts on the part of all relevant players in the research to policy 
process can ensure that such strategies are both implemented and evaluated. 
Through these means, policy-makers in countries such as Mali will be better 
equipped and informed to allow them to address the many complicated and 
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APPENDIX 1: INTERVIEW GUIDE 
 
(English version. Actual interviews were conducted in French.) 
 
Section A: Context/introduction 
 
1. Confirm the role of the interviewee in his/her decision-making status for the 
selection of Mali’s essential medicines list (EML). To what extent? How many 
years? 
 
Section B: The decision making process 
 
1. Could you describe the process of selecting the medicines for the national list? 
 
2. According to you, what is the purpose of an essential medicines list? 
 
3. What do you think are the most important criteria to consider when selecting a 
drug for the EML? [Probe: safety, access, price, efficacy, pattern of prevalent 
diseases, current use in the country, single compound, generic available, 
availability on the international market]  
 
Section C: The informants. Information mapping. 
 
1. From whom do you take advice during the process of updating the essential 
medicines list? 
 
2. Do you take advice from “non-experts” whose values you greatly trust? 
 
3. Which other individuals, groups, or organizations are important? [Probe: 
ministers; legislature; officials; networks; professional groups; advocacy groups; 
academics/researchers; specific research centers; international organizations; 
industry; NGOs; political parties; religious leaders; mass media; the public] 
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4. Is there a situation when you would want to select a medicine that is not on the 
WHO essential medicines list? Example? 
 
5. Is there a situation when you would not want to select a medicine that is on the 
WHO essential medicines list? Example? 
 
6. To which ways of communicating or discussing the information with informants 
were you most receptive, or found most useful. 
 
Section D: Importance of scientific research for making decisions 
 
1. What type of information do you consider most important when considering the 
addition or removal of a medicine to/from the list? 
 
2. How important do you consider scientific research when making decisions about 
which medicines to select for the National EML? [Probe: relative importance of 
experience compared to research] 
 
3. How well equipped was the selections committee to absorb research findings? 
[Probes: levels of training that members had in research methods; the use of 
policy analysis; the willingness to participate in official committees of policy-
makers and scientists; and the degree of contact built up with researchers]. 
 
Section E: Specific utilization of research 
 
1. Can you think of an example of a particularly difficult decision that was made? 
(Probes: WHO vs Mali list; old list vs new list; traditional medicines) 
 
2. Were you able to use research findings to help make that decision? If so, from 
which source? From whom? [Probes: national or international research; 
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systematic reviews; meta-analyses; Cochrane; national or international scientific 
literature; research reports; briefs of research findings produced by researchers; 
direct communication with individual researchers; attendance at seminars where 
research findings were presented; liaison with research centers; reports from 
official policy/science committees; briefs from research 
brokers/promoters/translators; briefs from policy advisers or officials; networks 
consisting of interest groups and other stakeholders; mass media; and dialogue 
with international agencies. Also Probe: informants mentioned in Section C] 
 
3. Were there specific features of this research that made it useful? [Probe: type of 
information it provided, quality, timeliness] 
 
4. Can you think of an example where more research information was needed? 
 
5. Can you think of an example where the research presented was not useful to help 
you make your decision? 
 
6. Were there reasons why research did not influence the decision to the extent that 
it could have done? 
 
7. What factors do you believe could make policy-makers more receptive to 
research? 
 
Section F: Research as support 
 
1. Were the research findings useful in supporting the decisions, to help 
communicate the policy or to generate support for it in terms of financial 
resources, political commitment, public opinion? 
 
2. Were the findings drawn upon in any speech, article, interview, report etc given to 
anyone at a higher level to support the decisions? 
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Section G: Unique to the list: traditional medicines - if not discussed above 
 
1. Why did you decide to look into traditional medicines? 
 
2. Were there any particular research findings that were used for deciding to choose 
these 7 medicines? Please give examples. 
 
3. Who were the informants that led to the addition of these medicines to the list? 
 
4. Why are these medicines in a separate category of their own instead of being 
placed in their respective treatment categories? 
 
5. Why are the improved traditional medicines on the essential medicines list but not 
in the therapeutic guidelines? 
 
Section H: Conclusion 
 
1. Do you have anything else you might like to add, specifically related to the main 
question here: what are the factors influencing policy-makers’ utilization of 
research findings? 
 
Section I: Document checklist 
 
1. Terms of reference for committee or guidelines for the selection proceedings 
 
2. Minutes from meetings with the selections committees 
 
3. Submissions to the committee 
 
4. Any other material used by selections committee 
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APPENDIX 2: INFORMED CONSENT 
 





Health Research Utilization Study 
Informed Consent Form 
 
 
The purpose of this study is to examine the factors affecting the use of research findings 
by health policy decision makers in the selection of a developing country’s essential 
medicines list (EML). If you participate in the study you will be involved in an in-depth 
interview, lasting no more than an hour. The interviewer will ask you questions 
concerning the decision making processes for selecting medicines for Mali’s EML. 
 
Your participation in this study is completely voluntary. Choosing to participate or not 
participate in the study will not have any negative repercussions. You are completely free 
to decline any part of the research, to choose not to answer any questions posed by the 
interviewer, to ask to have the audio recording turned off, or to withdraw from the study 
at any time without penalty. Both the audio recording used in the interview and the 
information obtained from the interview in the form of transcribed texts or notes will 
remain completely confidential. Names and/or any other identifiers that arise from the 
research interview will be altered in order to preserve your anonymity. 
 
If you have any questions, please do not hesitate to ask the Principle Investigator, 
Michael Albert. You may also contact his supervisor, Dr. Atle Fretheim of the Norwegian 
Knowledge Centre for Health at (+47) 24 16 3296 or at atle.fretheim@nokc.no before or 






Signature: ______________________________________ Date: ___________________ 
 
 
Name (please print): _____________________________________ 
 
 
 
 
